Multiple sclerosis (MS) is a disease of the central nervous system, estimated to affect 2.3 million people worldwide. It is a chronic disease in which the immune system abnormally attacks the insulation and support around the nerve cells (myelin sheath) in the brain, spinal cord and optic nerves, causing inflammation and consequent damage. MS is a leading cause of non-traumatic disability in young people, usually striking between 20 and 40 years of age. There is no cure for MS, but research continues to better understand and treat the disease.
Clinical trials are essential to improving the lives of those living with chronic conditions like multiple sclerosis (MS). To help navigate this journey, we’ve introduced a new resource: “What does clinical research in MS mean for me?” Co-created with the Roche MS Patient Squad—a global group of patient advocates—this guide is designed for individuals living with MS, their families, and care partners. It provides a clear look into:
Click to download – What does clinical research in MS mean for me?
Learn more about multiple sclerosis and research at Roche.
For patients in the US, learn more about multiple sclerosis and research at Genentech.